Guardian Technologies Forms new Applied Visual Sciences Healthcare Subsidiary
Complete the form below to unlock access to ALL audio articles.
Guardian Technologies International has announced that it has formed Applied Visual Sciences, Inc. as a wholly-owned subsidiary that will be focused on accelerating the commercialization of the Company’s next-generation disease detection technology for the healthcare industry.
“The future of medicine lies in the delivery of sophisticated imaging techniques and technologies that provide doctors with enhanced visualization and detection capabilities to more accurately diagnose disease states and substantially reduce misdiagnosis,” said Michael Trudnak, Chairman and Chief Executive Officer of Guardian Technologies International.
Trudnak continued, “The early successes we have experienced with Signature Mapping moved the timeline forward to create this subsidiary to concentrate our commercialization efforts and maximize shareholder value.”
Signature Mapping is an advanced analysis and visualization technology that can be installed to read images from any medical imaging device (including MRIs, CT-scans and x-rays) to detect disease states in the brain, lungs, heart, prostate and can even visualize breast cancer in difficult to distinguish dense breast tissue.
Recently, Guardian announced the completion of a pivotal test that showed Signature Mapping achieved a 97.5 percent detection rate (sensitivity) on cancer cases, with just 2.5 percent false negatives (cancer lesions undetected). These results are particular promising given that current mammography procedures yield an 80% accuracy rate, leading to more than 1 million unnecessary biopsies each year.
